IL17A and ulcerative colitis: Since Interleukin 17 (IL-17A) is one of the key salivary mediators in immune response and protection against Candida in the oral cavity [26] previous research by Larussa et al. [36] suggested the effectiveness of oleuropein from OLE in reducing IL-17A expression in patients with ulcerative colitis.